Name | Value |
---|---|
Revenues | 1,203.2K |
Cost of Revenue | 421.4K |
Gross Profit | 781.8K |
Operating Expense | 2,742.7K |
Operating I/L | -1,960.9K |
Other Income/Expense | 192.2K |
Interest Income | 25.4K |
Pretax | -1,768.7K |
Income Tax Expense | -10.5K |
Net Income/Loss | -1,768.7K |
NeuroMetrix, Inc. is a healthcare company specializing in designing, building, and marketing medical devices for nerve stimulation and analysis. Its primary products include DPNCheck for evaluating peripheral neuropathies, Quell for chronic pain relief, and the ADVANCE system for nerve conduction studies. The company targets various healthcare professionals and organizations, including managed care organizations, endocrinologists, podiatrists, primary care physicians, and pain medicine physicians. NeuroMetrix generates revenue by selling these medical devices to a wide range of healthcare providers and specialists across the United States, Europe, Japan, China, the Middle East, and Mexico.